Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078390 · ClinicalTrials.gov registry record · Phase 1
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
A Phase 1 study of Non-Small Cell Lung Cancer and Lung Cancer, sponsored by Shionogi.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 5
- Study locations
NCT00078390: Completed Phase 1 study of Non-Small Cell Lung Cancer and Lung Cancer, sponsored by Shionogi.
NCT00078390 is a Phase 1 study of Non-Small Cell Lung Cancer and Lung Cancer that has completed, run by Shionogi. The registered enrollment target is 9 participants, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00078390, a Phase 1 study of Non-Small Cell Lung Cancer and Lung Cancer, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 5
- Study locations
Study Summary
A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.
Conditions Studied
Interventions
- DRUG S-3304
- OTHER Chemo-irradiation
Study Locations (5)
California
- Scripps Cancer Institute - La Jolla
District of Columbia
- Lombardi Cancer Center - Washington D.C.
Kansas
- University of Kansas Cancer Center - Kansas City
New Jersey
- VA Medical Center-East Orange (study available to veterans only) - East Orange
Ohio
- The Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-10-26 |
| Phase | Phase 1 |
What the finished NCT00078390 record still lists
NCT00078390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which S-3304 is the first listed.
NCT00078390 lists 5 locations in 5 states (California, District of Columbia, Kansas).
Frequently Asked Questions
What is clinical trial NCT00078390 about?
NCT00078390 is a clinical study titled "Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer". A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.
What is the current status of trial NCT00078390?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2003-02. Estimated completion is 2006-10-26.
What conditions does trial NCT00078390 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer, Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIA Non-Small Cell Lung Cancer.
What interventions are being tested in trial NCT00078390?
The interventions under investigation include: S-3304 (DRUG), Chemo-irradiation (OTHER).
Who is sponsoring clinical trial NCT00078390?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00078390 being conducted?
This trial has 5 study locations across California, District of Columbia, Kansas, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00078390's enrollment target sits among peer trials
9 447th of 454 higher than 7 of 454 other Non-Small Cell Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
-
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia